首页> 外文期刊>Ophthalmology >Macular translocation in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization.
【24h】

Macular translocation in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization.

机译:黄斑易位患者复发性小凹脉络膜新生血管在激光光凝治疗后复发。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To report visual outcomes and to examine surgical factors affecting outcomes in patients undergoing macular translocation for recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization. DESIGN: Retrospective, noncomparative, interventional case series. PARTICIPANTS: A consecutive series of 31 eyes of 29 patients who underwent macular translocation for recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization. INTERVENTION: Inferior macular translocation with punctate retinotomy performed by a single surgeon. OUTCOME MEASURES: Surgical and visual outcomes at 3 and 6 months after surgery and complications data are reported. Associations between surgical factors and visual outcomes were analyzed statistically. RESULTS: Effective translocation was achieved in 77.4% of eyes. At 6 months, 54% of eyes achieved visual acuity (VA) better than 20/100, and 46% of eyes gained the equivalent of > or =2 Early Treatment Diabetic Retinopathy Study lines of vision. No association between size of recurrent choroidal neovascularization and visual outcome was identified. Eyes with a larger scar size experienced lower VA at 3 and 6 months, but scar size was not associated with change in VA at 3 and 6 months. Subretinal dissection during surgery to detach the macula was required in 8 of 31 eyes and was associated with a significantly increased incidence of peripheral retinal breaks. However, there was no difference in either VA or change in VA in eyes with and without subretinal dissection. Retinal detachment (RD) occurred in 6 of 31 eyes. No significant difference in the RD rate was observed between groups with or without subretinal dissection (P = 0.30). CONCLUSION: Our pilot data suggest that macular translocation can result in favorable surgical outcomes in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization. Use of subretinal dissection intraoperatively in these patients does not seem to affect visual outcome adversely, but may be associated with increased risk of peripheral retinal breaks.
机译:目的:报告视觉结果并检查影响黄斑易位患者复发性黄斑下凹脉络膜新生血管的激光光凝治疗后黄斑移位的结果。设计:回顾性,非比较性,介入性病例系列。参与者:29例患者的31眼连续系列患者接受了黄斑移位术,进行了激光光凝治疗后的黄斑移位,继发了非黄斑下脉络膜新生血管。干预:由一名外科医生进行黄斑下移位并进行点状视网膜切开术。观察指标:报告了术后3个月和6个月的手术和视觉结果以及并发症数据。手术因素和视觉结果之间的关联进行了统计分析。结果:77.4%的眼睛有效移位。在6个月时,有54%的眼睛获得了高于20/100的视敏度(VA),有46%的眼睛获得了≥2的早期治疗糖尿病性视网膜病研究视线。复发性脉络膜新生血管的大小与视觉结果之间没有关联。疤痕较大的眼睛在3和6个月时的VA较低,但疤痕大小与3和6个月时的VA变化无关。 31眼中有8眼需要在手术过程中进行视网膜下剥离以剥离黄斑,这与周围视网膜断裂的发生率显着增加有关。但是,在有和没有视网膜下剥离的眼中,VA或VA的变化均无差异。 31只眼中有6只发生了视网膜脱离(RD)。在有或没有视网膜下剥离的组之间,RD率无显着差异(P = 0.30)。结论:我们的试验数据表明,黄斑移位术可对非小凹下脉络膜新生血管进行激光光凝后复发性小凹下脉络膜新生血管的患者获得良好的手术效果。在这些患者中,术中使用视网膜下剥离术似乎不会对视力产生不良影响,但可能与周围性视网膜破裂风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号